szl 49 has been researched along with oxymetazoline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daniel, EE; Hoo, KH; Kwan, CY | 1 |
| Amobi, N; Guillebaud, J; Kaisary, A; Lloyd-Davies, RW; Smith, IC; Turner, E | 1 |
2 other study(ies) available for szl 49 and oxymetazoline
| Article | Year |
|---|---|
Investigation of alpha 1-adrenoceptor subtypes in canine aorta, using alkylating agents.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Alkylating Agents; Animals; Aorta; Binding, Competitive; Clonidine; Dioxanes; Dogs; Female; In Vitro Techniques; Male; Mesenteric Veins; Muscle, Smooth, Vascular; Oxymetazoline; Prazosin; Radioligand Assay; Receptors, Adrenergic, alpha-1 | 1994 |
Contractile actions of imidazoline alpha-adrenoceptor agonists and effects of noncompetitive alpha1-adrenoceptor antagonists in human vas deferens.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Dibenzylchlorethamine; Dose-Response Relationship, Drug; Humans; Imidazoles; Male; Muscle Contraction; Norepinephrine; Oxymetazoline; Phenoxybenzamine; Prazosin; Receptors, Adrenergic, alpha-1; Tetrahydronaphthalenes; Vas Deferens | 2003 |